|
Edesa Biotech, Inc. (EDSA) DCF -Bewertung
CA | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Edesa Biotech, Inc. (EDSA) Bundle
Erforschen Sie die finanzielle Zukunft von Edesa Biotech, Inc. (EDSA) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Projektionen für Wachstum, Margen und Kosten ein, um den inneren Wert von Edesa Biotech, Inc. (EDSA) zu berechnen und Ihre Anlagestrategie zu verfeinern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -100 | 0 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -6.3 | -13.2 | -17.4 | -8.2 | -6.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1929.83 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .1 | .1 | .1 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 17.51 | 100 | 100 | 100 | 100 | 83.5 | 83.5 | 83.5 | 83.5 | 83.5 |
| EBIT | -6.4 | -13.3 | -17.5 | -8.4 | -6.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -1947.33 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 7.2 | 7.8 | 7.1 | 5.4 | 1.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | 3.3 | 1.3 | .6 | .3 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 26.6 | 100 | 100 | 100 | 100 | 85.32 | 85.32 | 85.32 | 85.32 | 85.32 |
| Inventories | -.1 | .0 | -1.3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | -26.6 | 100 | 100 | 100 | 100 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 |
| Accounts Payable | 1.5 | 1.4 | 2.1 | 1.7 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 444.08 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -10.44 | 100 | 100 | 100 | 100 | -2.09 | -2.09 | -2.09 | -2.09 | -2.09 |
| Tax Rate, % | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 | -0.01296755 |
| EBITAT | -6.4 | -13.3 | -17.5 | -8.4 | -6.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4.9 | -16.6 | -13.4 | -9.2 | -7.5 | .3 | .0 | .0 | .0 | .0 |
| WACC, % | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | 1 | |||||||||
| Diluted Shares Outstanding, MM | 3 | |||||||||
| Equity Value Per Share | 0.40 |
What You Will Get
- Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Edesa Biotech, Inc. (EDSA) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that caters to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Historical Data: Edesa Biotech’s past financial statements and pre-populated projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Monitor Edesa Biotech’s intrinsic value recalculating instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Edesa Biotech data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Edesa Biotech’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Edesa Biotech, Inc. (EDSA)?
- Accuracy: Utilizes real Edesa financial data for precise calculations.
- Flexibility: Allows users to easily adjust and test various input parameters.
- Time-Saving: Eliminates the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying levels of financial knowledge.
Who Should Use This Product?
- Investors: Evaluate Edesa Biotech's valuation before making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation processes of biotech companies like Edesa Biotech.
- Consultants: Provide detailed valuation analyses and reports for clients in the biotech sector.
- Students and Educators: Utilize current market data to learn and teach valuation strategies.
What the Template Contains
- Historical Data: Includes Edesa Biotech’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Edesa Biotech’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Edesa Biotech’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.